Tatva Chintan Q2 Results October 19, 2026: Profit Up 116% on Record Revenue, but Margins Lag

Tatva Chintan Q2 results came with a headline any chemical maker would like: the highest quarterly turnover in the company’s history. The specialty chemicals maker, whose plants are at Ankleshwar and Dahej in Gujarat, said on October 19, 2026 that consolidated revenue from operations rose 76% year-on-year to ₹217.3 crore for the September quarter, and profit after tax more than doubled, up 116% to ₹21.5 crore, according to its investor presentation filed with BSE.

Tatva Chintan Q2 results in numbers

All figures below are consolidated and come from the company’s presentation, which reports in ₹ million. We have converted them to crore.

• Revenue: ₹217.3 crore, against ₹123.5 crore a year ago (up 76%) and ₹167.1 crore in the June quarter (up 30%).
• EBITDA excluding other income: ₹40.7 crore, up 83% from ₹22.2 crore.
• EBITDA margin: about 19%, against 18% a year ago and 19% in Q1.
• Profit after tax: ₹21.5 crore, up from ₹9.9 crore a year ago and ₹16.0 crore in Q1. PAT margin was 9.9%.
• First half: revenue of ₹384.4 crore, up 60%, and PAT of ₹37.4 crore, up 126%.

Trade Brains reported the same headline numbers to two decimals: revenue of ₹217.32 crore and net profit of ₹21.45 crore. On a standalone basis, revenue was ₹207.48 crore and profit ₹15.39 crore.

Where the growth came from

Structure directing agents (SDA) made up 45% of Q2 revenue, up from 41% for FY26 as a whole. Chairman and MD Chintan Shah linked this to Euro 7 emission norms, which he said are already showing up in sales. Pharma, agro and speciality chemicals were 30%, phase transfer catalysts 21% and electrolyte salts and solutions for energy storage 3%.

The catch: margins did not keep pace

Revenue jumped, but margin barely moved. Shah was candid about it in his message. Short supply pushed up prices of some solvents by 60% to 100%, and the company uses several of them in large volumes. Freight to parts of the US and Europe rose by more than 100%. He said both trends have started to reverse and he expects them to normalise within the third quarter. That is a forecast, not a result, and the December quarter will test it.

The balance sheet is worth a look too. Between March 31 and September 30, 2026, trade receivables rose from about ₹119 crore to ₹178 crore, roughly 50% by our arithmetic. Inventory went up about 27% to ₹249 crore, and short-term borrowings rose about 43% to ₹166 crore. Some of that is natural when sales grow this fast. But it means more cash is tied up in working capital, and we would want to see collections catch up. Our guide to reading quarterly results explains why this matters as much as the profit line.

Two filings that raised eyebrows

The company cancelled its 5 pm earnings call on the same day, citing “unforeseen circumstances”, so analysts did not get to question management. Later that evening it filed an updated presentation fixing typographical errors on one page. First-half return on equity was corrected to 6.3% from 2.6%, and annualised debt to EBITDA to 1.16 times from 4.30. The company said no other financial numbers changed.

What to watch on Wednesday

The results landed at the very end of Monday’s session (the board meeting ended at 3:45 pm), and Trade Brains put the share at ₹1,903.40 that day, down 2.09%. With markets shut today for Dussehra (details in our holiday note), Wednesday is the first full session to react. The full October 19 results line-up has the other companies that reported the same day.

Our take: the growth is real, and the SDA business looks like it is carrying the company. What’s missing is a clear sign that higher sales are turning into wider margins, and the cancelled call left that question hanging.

Disclaimer: This article is for information only and is not investment advice or a recommendation to buy or sell any security. Figures are from Tatva Chintan’s filings with BSE and a report by Trade Brains, all linked above. Please consult a SEBI-registered investment adviser before making any investment decision.